M, N. K., Dinarv, R, M, A., H, R., S, E., . . . F, A. (2011). Docetaxel immunonanocarriers as targeted delivery systems for HER2-positive tumor cells: Preparation, characterization, and cytotoxicity studies. Dove Medical Press.
Cita Chicago Style (17a ed.)M, Noori Koopaei, Dinarv, R, Amini M, Rabbani H, Emami S, Ostad SN, y Atyabi F. Docetaxel Immunonanocarriers as Targeted Delivery Systems for HER2-positive Tumor Cells: Preparation, Characterization, and Cytotoxicity Studies. Dove Medical Press, 2011.
Cita MLA (8a ed.)M, Noori Koopaei, et al. Docetaxel Immunonanocarriers as Targeted Delivery Systems for HER2-positive Tumor Cells: Preparation, Characterization, and Cytotoxicity Studies. Dove Medical Press, 2011.
Precaución: Estas citas no son 100% exactas.